Additionally, iTBS may protect against motor deficits and neuronal damage caused by stroke by inhibiting the TLR4/NF-κB/NLRP3 signaling pathway, thereby regulating the M1/M2 phenotype balance in microglia (45). The gene discussed is NLRP3; the disease is Stroke.